Lifastuzumab vedotin
Lifastuzumab vedotin is an antibody-drug conjugate designed to treat cancer. It is composed of the monoclonal antibody lifastuzumab linked to the cytotoxic agent monomethyl auristatin E (MMAE). The antibody portion of the drug binds to HER3, a protein that is overexpressed in certain types of cancer, and delivers the cytotoxic agent directly to the cancer cells.
Mechanism of action[edit | edit source]
Lifastuzumab vedotin works by targeting the HER3 protein on the surface of cancer cells. The lifastuzumab portion of the drug binds to HER3, and the drug is then internalized by the cell. Once inside the cell, the MMAE is released and interferes with cell division, leading to cell death.
Clinical trials[edit | edit source]
Lifastuzumab vedotin has been tested in clinical trials for the treatment of various types of cancer, including breast cancer, lung cancer, and gastric cancer. However, the results of these trials have been mixed, and the drug is not currently approved for use in any country.
Side effects[edit | edit source]
The most common side effects of lifastuzumab vedotin include fatigue, nausea, and decreased appetite. More serious side effects can include neutropenia, peripheral neuropathy, and pulmonary toxicity.
See also[edit | edit source]
| Lifastuzumab vedotin Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
